Home » Prices » NASDAQ:CNAT

Conatus Pharmaceuticals Inc. stock price

Today's NASDAQ:CNAT chart, history & news

Price:
0.56 USD
Change:
+0 (0%)
Key Stats
Price open
Previous close 0.556
Market cap 18.44M
Volume 0
Day high 0.594
Day low 0.5406
Year high 1.07
Year low 0.2303
Year to date change 41.48%
P/E Ratio -1.82
Company Profile
Fundamentals
Insider Information
News

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA.

Company information

Company name
Conatus Pharmaceuticals, Inc.
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
6
CEO
Steven J. Mento
Address
16745 West Bernardo Drive, San Diego, CA, 92127-7619
Country
United States
Contact information
1.858.376.2600
Website
http://www.conatuspharma.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.